Endava plc (DAVA), the London-headquartered digital transformation and IT-services company that trades on the NYSE through ADS (American Depositary Shares), has been one of the most volatile names in the software-services sector over the past year. After an accounting investigation, a pending restatement, and a sweeping leadership overhaul, its shares have collapsed from a 52-week high near $9.47 to roughly $1.69. The question facing investors is whether the stock can recover toward the $4 analyst price target that still sits on the books.
The $4.00 central target is the simple average of five attributed targets that could be verified with a firm, analyst, and date: Morgan Stanley (James Faucette) at $4.00 with a Hold rating dated November 9, 2026; Deutsche Bank at $2.00 with a Hold rating on September 22, 2026; TD Cowen (Bryan Bergin) at $3.50 with a Hold rating on July 9, 2026; and J.P. Morgan at $5.00 (Underweight) and Needham at $5.00 (Buy), both from late May 2026. The approximate range of these targets is $2.00 to $5.00.
That range is unusually wide, and the dispersion is meaningful. The most bearish targets reflect the September 2026 accounting revelations, while several higher targets predate them and may not yet incorporate the restatement risk. William Blair moved to a Sell-equivalent rating without a price target in September 2026, and Guggenheim downgraded the stock to Neutral in May 2026. Overall, the analyst consensus leans toward a cautious "Hold," with genuine disagreement between a lone Buy and the more defensive ratings.
Endava's ADS traded near $1.69 in early November 2026, just above its 52-week low of $1.52 and far below its 52-week high of $9.47. Reaching $4.00 would require a gain of roughly 137%, which is a very large move by any standard. The stock has shed more than 80% of its value over the trailing twelve months.
The path toward the target is complicated by the fact that Endava has withdrawn its fiscal 2026 guidance and delayed its annual report beyond its November 2, 2026 deadline. On October 28, 2026, the company said its audit committee investigation found that certain fiscal 2026 customer-and-supplier agreements "lacked economic substance," requiring a restatement of results with revenue adjustments equal to roughly 2% to 4% of prior-year revenue. Until audited figures are published, fundamental valuation of the stock is difficult, and the negative trailing EPS (earnings per share) leaves standard P/E (price-to-earnings) analysis of little use.
The most concrete support is Endava's stated liquidity of approximately £55 million in cash as of September 30, 2026, which could give the company room to work through its restatement and remediation. Strategically, management continues to emphasize an AI-focused transformation and long-standing client relationships, which some analysts cite as a reason to expect a recovery if client demand stabilizes. A resolution of the accounting review, a credible restated balance sheet, and any sign that revenue attrition is slowing could prompt analysts to revisit their lower targets and improve sentiment toward the name.
The obstacles are substantial. The company faces a securities class action with a November 30, 2026 lead-plaintiff deadline, an ongoing investigation, material weaknesses in internal controls over financial reporting, and the possibility that a restatement could affect compliance with debt covenants under its revolving credit facility. Leadership instability adds further risk: the CFO resigned, the CEO moved to a non-executive advisory role, and the General Counsel stepped down, with an interim CEO and interim CFO now in place. Perhaps most pressing, a share price near $1.69 sits uncomfortably close to the NYSE's threshold for delisting if the stock trades below $1.00 for an extended period. Client and employee confidence, already tested, could erode further as procurement decisions are delayed.
From a technical standpoint, Endava is in a pronounced long-term downtrend. The shares broke down sharply on September 22, 2026, falling about 24% to close near $2.11 after the CFO was placed on administrative leave, and they have since drifted toward the $1.52 low. The $2.00 to $2.24 zone represents a notable prior breakdown area that could now act as resistance, and $2.79 marks the level just before the accounting disclosure. The psychological $1.00 level is the most important floor to monitor given listing rules, while $9.47, the 52-week high, remains a distant reference point rather than a near-term objective.
Analyst price targets generally reflect a research horizon of roughly twelve months, though the precise horizon is not uniform across firms, and several of Endava's targets were set before the September 2026 disclosures. Key items to watch include the filing of restated fiscal 2026 results and the delayed annual report, any findings on credit-covenant compliance and lender discussions, the outcome of the securities litigation, the appointment of permanent executive leadership, and any further disclosure about client retention and revenue trends. An SEC or UK regulatory inquiry, while not yet announced, would be a material development if it emerged.
For traders navigating a high-uncertainty name like Endava, Tickeron's AI Daily Buy/Sell Signals offer a data-driven complement to fundamental research. The tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. Traders can use it to discover opportunities, monitor existing positions, and spot changing trends more efficiently than manual screening allows. Explore the signals to see how AI-driven monitoring can support a more disciplined decision process.
Can Endava reach $4.00? The $4.00 level is not an official published consensus but the arithmetic mean of five verified analyst targets, rounded from $3.90, within a wide $2.00-to-$5.00 range. From roughly $1.69, that implies a very large move of about 137%. The strongest supports are the company's stated cash position and its AI-oriented strategy, while the principal obstacles are the accounting restatement, delayed filings, leadership turnover, litigation, and potential listing pressure. Given the wide analyst disagreement and the unresolved governance questions, the $4.00 target should be read as a reference point rather than a forecast, and the restated financials and leadership appointments will be the most important signals to watch.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, DAVA has been loosely correlated with COIN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if DAVA jumps, then COIN could also see price increases.
| Ticker / NAME | Correlation To DAVA | 1D Price Change % | ||
|---|---|---|---|---|
| DAVA | 100% | -1.18% | ||
| COIN - DAVA | 51% Loosely correlated | -2.92% | ||
| CLSK - DAVA | 50% Loosely correlated | -4.92% | ||
| RIOT - DAVA | 48% Loosely correlated | +2.38% | ||
| ALIT - DAVA | 46% Loosely correlated | -3.48% | ||
| HUBS - DAVA | 46% Loosely correlated | -4.34% | ||
More | ||||
| Ticker / NAME | Correlation To DAVA | 1D Price Change % |
|---|---|---|
| DAVA | 100% | -1.18% |
| Computer Communications industry (166 stocks) | 1% Poorly correlated | +2.58% |